Lactose protects against estrogen-induced pigment gallstones in hamsters fed nutritionally adequate purified diets.
To evaluate the impact of dietary factors on gallstone induction in hamsters, male Syrian hamsters were fed for 2-8 wk purified diets that varied in type and amount of simple sugar (glucose vs. lactose, 17.5-72%), fat (2-5%), fiber (0-15%) and estrogen (0 or 300 micrograms/kg diet). Plasma and liver cholesterol and plasma triglycerides were measured, daily weight gain was determined, cecal weights were obtained, and gallbladder bile was scored by light microscopy and analyzed chemically for its lithogenicity and gallstone incidence. Lactose reduced plasma lipids, especially triglycerides, and hepatic cholesterol accumulation, and maintained a lower biliary cholesterol concentration. When fed at 30% or more, lactose reduced weight gain, increased cecal volume 2- to 4-fold and prevented gallstone formation. Diarrhea and death from 'wet tail' was associated with gallstones and was frequent in hamsters fed glucose without fiber, but its incidence was essentially eliminated by rice flour plus fiber or lactose. Under these experimental conditions of time and diet, estrogen supplementation was required for the formation of gallstones. These appeared to be pigment stones containing a minimal amount of cholesterol. In summary, pigment gallstones were induced in less than 8 wk in hamsters fed estrogen-supplemented purified diets. Lactose feeding improved lipid metabolism and reduced gallstone formation, apparently through its impact on large bowel metabolism.
Hayes
K C
KC
Foster Biomedical Research Laboratory, Brandeis University, Waltham, MA 02254.
Stephan
Z F
ZF
Pronczuk
A
A
Lindsey
S
S
Verdon
C
C
D000818:Animals; D001646:Bile / Q000378:metabolism; D002769:Cholelithiasis / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D002791:Cholesterol, Dietary / Q000378:metabolism / Q000494:pharmacology; D006224:Cricetinae; D004040:Dietary Carbohydrates / Q000008:administration & dosage / Q000494:pharmacology; D004043:Dietary Fiber / Q000494:pharmacology; D004195:Disease Models, Animal; D004967:Estrogens / Q000009:adverse effects / Q000494:pharmacology*; D005526:Food, Formulated; D007785:Lactose / Q000008:administration & dosage / Q000494:pharmacology*; D008055:Lipids / Q000097:blood; D008297:Male; D008647:Mesocricetus; D009751:Nutritional Requirements; D010859:Pigmentation Disorders / Q000209:etiology / Q000517:prevention & control*
D002791:Cholesterol, Dietary; D004040:Dietary Carbohydrates; D004043:Dietary Fiber; D004967:Estrogens; D008055:Lipids; D007785:Lactose